Utah Medical Products

(NASDAQ) UTMD

Current Price$64.85

Market Cap$207.12M

Since IPO (1989)+5,384%

5 Year-18%

1 Year+26%

1 Month+0%

Utah Medical Products Financials at a Glance

Market Cap

$207.12M

Revenue (TTM)

$37.53M

Net Income (TTM)

$10.85M

EPS (TTM)

$3.38

P/E Ratio

19.24

Dividend

$1.23

Beta (Volatility)

0.53 (Low)

Dividend

$1.23

Beta (Volatility)

0.53 (Low)

Price

$64.85

Volume

463

Open

$66.94

Price

$64.85

Volume

463

Open

$66.94

Previous Close

$64.85

Daily Range

$64.62 - $66.94

52-Week Range

$51.75 - $71.81

Dividend

$1.23

Beta (Volatility)

0.53 (Low)

Price

$64.85

Volume

463

Open

$66.94

Previous Close

$64.85

Daily Range

$64.62 - $66.94

52-Week Range

$51.75 - $71.81

UTMD News

Utah Medical Products Reports Q2 Decline

Motley Fool Markets TeamJul 25, 2025

1 Reason to Expect Big Things from Utah Medical Products

Seth JaysonJul 17, 2013

UTMD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Utah Medical Products

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

183

CEO

Kevin Leighton Cornwell, MBA

Website

www.utahmed.com

Headquarters

Midvale, UT 84047-1048, US

UTMD Financials

Key Financial Metrics (TTM)

Gross Margin

54%

Operating Margin

29%

Net Income Margin

29%

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

5.20%

Dividend Yield

1.89%

Payout Ratio

36.72%

Stock Overview

Market Cap

$207.12M

Shares Outstanding

3.19M

Volume

463

Avg. Volume

14.88K

Financials (TTM)

Gross Profit

$19.88M

Operating Income

$11.40M

EBITDA

$17.06M

Operating Cash Flow

$14.69M

Capital Expenditure

$371.00K

Free Cash Flow

$14.32M

Cash & ST Invst.

$85.76M

Total Debt

$225.00K

Utah Medical Products Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$8.72M

-10.2%

Gross Profit

$5.28M

-4.6%

Gross Margin

60.56%

N/A

Market Cap

$207.12M

N/A

Market Cap/Employee

$1.34M

N/A

Employees

155

N/A

Net Income

$2.60M

-14.4%

EBITDA

$2.56M

-38.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$87.20M

+5.0%

Accounts Receivable

$3.64M

-7.8%

Inventory

$8.72M

+0.9%

Long Term Debt

$210.00K

-21.9%

Short Term Debt

$0.00

N/A

Return on Assets

8.72%

N/A

Return on Invested Capital

8.95%

N/A

Free Cash Flow

$3.37M

+15.0%

Operating Cash Flow

$3.48M

+18.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OSUROraSure Technologies, Inc.

OSUROraSure Technologies, Inc.$2.96-1.66%

CHRSCoherus Oncology, Inc.

CHRSCoherus Oncology, Inc.$1.74-1.69%

INFUInfuSystem Holdings, Inc.

INFUInfuSystem Holdings, Inc.$9.83-3.44%

PROFProfound Medical Corp.

PROFProfound Medical Corp.$6.55-2.24%

KRMDKORU Medical Systems, Inc.

KRMDKORU Medical Systems, Inc.$3.97-2.70%

PLXProtalix BioTherapeutics, Inc.

PLXProtalix BioTherapeutics, Inc.$2.12+0.00%

PREPrenetics Global Limited

PREPrenetics Global Limited$17.41-5.28%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

NOKNokia

NOKNokia$12.46+0.10%

INTCIntel

INTCIntel$94.75+0.12%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.08-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.93-0.02%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$42.75-0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.04%

Questions About UTMD

What is the current price of Utah Medical Products?

Utah Medical Products is trading at $64.85 per share.

What is the 52-week range for Utah Medical Products?

Over the past 52 weeks, Utah Medical Products has traded between $51.75 and $71.81.

How much debt does Utah Medical Products have?

As of the most recent reporting period, Utah Medical Products reported total debt of $210,000.

How much cash does Utah Medical Products have on hand?

Utah Medical Products reported $85.76M in cash and cash equivalents in its most recent financial results.

What is Utah Medical Products’s dividend yield?

Utah Medical Products currently has a dividend yield of 1.89%.

Utah Medical Products

Utah Medical Products Financials at a Glance

UTMD News

Utah Medical Products Reports Q2 Decline

1 Reason to Expect Big Things from Utah Medical Products

Buybacks: 4 Companies That Reward Shareholders

7 Health-Care Dividend Stocks Getting Slammed

5 Top Micro-Cap Stocks

UTMD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Utah Medical Products

UTMD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Utah Medical Products Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About UTMD

What is the current price of Utah Medical Products?

What is the 52-week range for Utah Medical Products?

How much debt does Utah Medical Products have?

How much cash does Utah Medical Products have on hand?

What is Utah Medical Products’s dividend yield?

Premium Investing Services